Re: Bisphosphonates and osteonecrosis - from an OMFS

From: art fougner, md (evsono@pipeline.com)
Mon Jun 5 13:28:27 2006


It's enough to want to return to writing ERT Rx's again.

art

At Mon, 5 Jun 2006, Meenan, Anna wrote: >
>I still agree with you, Kim. I'm really afraid we will be finding a
>lot more cases now that this is known, and I prefer to wait til I see
>how this all shakes out before aggressively promoting
>bisphosphonates. And again, my gut feeling for myself is that I
>would rather have a hip fracture than osteonecrosis of the jaw.
>Really.
>
>Anna Meenan, MD
>
>>I agree that telling our patients is important. Risks, benefits and
>>alternatives of ALL treatments. And yes, ultimately it should be a
>>well informed patient who chooses which risks they are willing to
>>take.
>>
>>As far as I know there are no significant side effects to a healthy
>>calcium rich diet and exercise to build bone mass now.
>>
>>You are correct that it is a rare side effect (though I suspect now
>>that it is "identified" the numbers reported will be increasing.
>>Almost every OMFS that I know can look back through their case load
>>and identify at least one patient, usually female, usually post or
>>perimenopausal, who had a non-healing "infection" that required
>>rather drastic measures to gain control).
>>
>>The landmark article (Ruggiero et. al.) reported 7 out of 63 (11%)
>>cases (not 6 out of 300 as was suggested below) caused by oral
>>bisphosphonate use. When you look at the large numbers of patients
>>on oral bisphosphonates that becomes a very significant potential
>>patient population. BAON is not just painful but deforming,
>>disfiguring and life changing. Some of these women have lost their
>>entire lower jaw necessitating G tube placement and tracheostomies.
>>If you believe that drooling or a drooping face due to a stroke is
>>deforming (and I agree that it is), then this is certainly a much
>>worse deformity that is cosmetically and functionally devastating.
>>
>>OCP's increase the risk of clots. HRT increases the risk of clots
>>and yet patients continue to take both of these. Smoking increases
>>the risk of clots and does nothing good for patients and yet despite
>>all our educational efforts patients also continue to smoke. All
>>medications have side effects. Because we do not understand the
>>mechanism here, because there are other methods for preserving and
>>improving bone mass, because the potential downside is so great, I
>>do not believe this is either an emotional or an illogical response.
>>
>>And hip fractures in the very elderly or infirm of either sex can
>>indeed be the "straw that breaks the camel's back" but interestingly
>>it is exceedingly rare for an elderly man to be placed on
>>bisphosphonates unless he is also a cancer patient. The statistics
>>below come from the British Medical Journal in a study that looked
>>at mortality at 30, 60, 90 and 365 days after surgery for fracture
>>of the femoral head and are food for thought.
>>
>>"fatality rates at 30 days in 1984-98 increased from 4% in men aged
>>64-69 years to 31% in those aged >= 90. They were higher in men than
>>women, and in social classes IV and V than in classes I and II."
>>
>>Now 31% seems like a very high number but so does age over 90. I
>>hope I am kicking around and healthy at 90 but let's face it, the
>>chances of mortality from any cause over the age of 90 should
>>certainly be higher than the chances of mortality from the same
>>cause at age 60.
>>
>>And osteoporosis is not the only factor in the increased risk for
>>hip fractures in the elderly. Multiple studies show that age,
>>underlying medical status, poor preinjury mobility, time spent in
>>the ER prior to surgery, non-use of thromboembolic prophylaxis
>>during hospital stay, male gender and poor discharge planning all
>>contribute significantly to increased morbidity and mortality from
>>hip fractures.
>>
>>So no, I do not believe this to be a "knee jerk" reaction. It is a
>>reasoned response, not the only one mind you but the one I have
>>developed after several years of consideration, constant review of
>>the literature and at least 7 years experience taking care of
>>patients who have had this devastating complication of
>>bisphosphonate therapy.
>>
>>Interestingly, if you go to the very old literature, there was a
>>similar phenomenon reported in workers in the match industry in the
>>mid-19th century. These were mostly young, healthy people who were
>>exposed to biologically active white phosphorus at their work place.
>>Chronic phosphorus exposure appeared to induce hyperostosis of the
>>entire skeletal structure and sequestration and nonhealing injuries
>>in both jaws. The phosphorus appeared to be more highly concentrated
>>in the jaws than elsewhere in the body. The mortality rate for this
>>disease in the preantibiotic era was estimated at ~ 20%. The
>>phenomenon was also seen in other industries where white phosphorus
>>was used (munitions, fireworks, brass manufacturers) and appears to
>>have been controlled and eradicated by industrial hygiene measures
>>which resulted in workers no longer being exposed to this
>>biologically active compound.
>>
>>It is all food for thought.
>>
>>On Jun 5, 2006, at 1:26 AM, Rafael Haciski wrote:
>>
>>>Isn't that a bit of an emotional response, and an illogical one at that?
>>>
>>>Being fully cognizant of the unpleasantness of osteonecrosis, and
>>>also acknowledging the probable underreporting of the incidence,
>>>the facts remain:
>>>.. ONJ is an exceedingly RARE event, (my understanding of the
>>>reported incidents is that there were approx. 6 cases out of 300
>>>who were taking oral bisphosphonates, the rest were on IV);
>>>.. the denominator are the millions of patients on oral bisphosphonates
>>>.. on the other hand, the incidence of bone fractures related to
>>>osteoporosis is close to 1,500,000 per year in the US
>>>.. in menopause, fatalities due to complications of hip fracture
>>>reach 30% within the year of fx
>>>.. Evista, HRT carry also the risk of DVT (you do not like what
>>>osteonecrosis may feel like, but how about drooling out of your
>>>mouth, being a paralyzed vegetable due to DVT?)
>>>
>>>If your logic were sound in trying to avoid this exceedingly
>>>uncommon complication, then you should avoid the much more common
>>>risks of other medications you mention, and indeed, you probably
>>>should stay at home and never venture out, as driving is the single
>>>most dangerous activity we undertake. Yet we choose to do it every
>>>day.
>>>
>>>We really have to moderate our knee jerk reactions, especially as
>>>those reactions filter out to the public who become totally
>>>confused by our fears and lack of understanding. WHI comes to mind
>>>- the premature release of incompletely digested and understood
>>>data caused much confusion and has been a disservice to our
>>>patients, and an added burden to us trying to explain to our
>>>patients what is going on and what they should do.
>>>
>>>At present, all I can tell my patients are the risks as we best
>>>understand them of BOTH sides of the equation, and let them choose.
>>>
>>>Rafael Haciski MD FACOG
>>>Palmetto, FL
>>>
>>>On Jun 4, 2006, at 2:59 PM, Meenan, Anna wrote:
>>>
>>>>Thank you so much for posting, Kim. Those have kind of been my
>>>>gut feelings since this story broke, and as a 52 y.o. thin,
>>>>half-Danish woman with a family history of osteoporosis and a
>>>>T-score of minus 1.8 (4 years ago, and I'm too chicken to get
>>>>another BMD now), this affects me personally. I've really been in
>>>>a quandary, because I know it's gong to come up at my next annual.
>>>>I also have an extreme case of dentalphobia, and even the thought
>>>>of someone digging dead pieces of bone out of my jaw gives me the
>>>>creeps.
>>>>
>>>>Anna Meenan, MD
>>>>
>>>>>I noted with interest that this topic is being discussed in OB-GYN
>>>>>forums and thought I would share what little we actually do know about
>>>>>this phenomenon. It is, unfortunately, very little but, as many of you
>>>>>have pointed out, the attorneys are ALL on to this already. It has been
>>>>>relatively well known in the oral surgery community for several years
>>>>>now but seems, only recently to have disseminated beyond that relatively
>>>>>small group of health care providers.
>>>>>
>>>>>1. Bisphosphonate related osteonecrosis (BRON) occurs in a very small
>>>>>percentage of patients on bisphosphonates but when it does occur it can
>>>>>be devastating.
>>>>>2. BRON is more common in patients receiving IV bisphosphonates but
>>>>>ABSOLUTELY DOES OCCUR in patients on oral medications only for the
>>>>>prevention of or treatment of osteoporosis.
>>>>>3. In many cases there is some minor oral injury (tooth extraction,
>>>>>denture sore, etc.) which precipitates the disease BUT THERE ARE ALSO
>>>>>CASES WHERE THIS OCCURS SPONTANEOUSLY.
>>>>>4. Taking patients off bisphosphonates may not lower their risk for an
>>>>>extended period of time or at all. We just don't know. We do know that
>>>>>bisphosphonates have a very long half life in bone.
>>>>>5. As of yet, there is no clear consensus on treatment though there is
>>>>>a great deal of work being done on clarifying and stratifying treatment
>>>>>modalities. It is still, quite often, a disease with extreme morbidity
>>>>>when it occurs.
>>>>>
>>>>>I believe that we will see increasing numbers of these cases reported.
>>>>>
>>>>>Personally, I have looked backward through my own cases and know of at
>>>>>least one case in the late 90's which must have been BRON.
>>>>>History is
>>>>>as follows. Otherwise healthy female (nurse at our hospital actually)
>>>>>in her late 50's whose only medication was a bisphosphonate. Saw her
>>>>>dentist, had tooth extracted, site didn't heal, tx'd with abx without
>>>>>resolution, referred to OMFS, multiple debridements without healing,
>>>>>referred to our teaching hospital where multiple services including ID
>>>>>were involved, workup for immune deficiency was negative, PICC line and
>>>>>long term abx failed to resolve issue....long story short she eventually
>>>>>lost almost half of her lower jaw.
>>>>>
>>>>>Since that time I have seen, treated or had colleagues in our practice
>>>>>treat several other cases. While the occurences are still relatively
>>>>>rare, as I stated before, when it is you or your patient, it is
>>>>>devastating.
>>>>>
>>>>>I am often asked by patients now what they should do about these drugs
>>>>>and my personal suggestions to patients at this point are as follows:
>>>>>
>>>>>First I share with them how little we actually know about this problem.
>>>>>For patients who will understand, I also provide copies of some of the
>>>>>landmark papers on the issue (Ruggerio et. al, Marx et. al.) I then
>>>>>share the following personal philosophies.
>>>>>
>>>>>1. No matter what your age now is the time to increase calcium intake,
>>>>>increase exercise and healthy life style choices, build bone mass now to
>>>>>prevent problems later.
>>>>>2. I would not personally take a bisphosphonate for prevention of
>>>>>osteoporosis.
>>>>>3. If I were already diagnosed with osteopenia or osteoporosis, I would
>>>>>look into nonbisphosphonate modalities such as Evista and HRT.
>>>>>4. IF *I* were on bisphosphonates I would discontinue them even knowing
>>>>>that we don't know if this is helpful or reduces risk long term.
>>>>>Teleologically it seems unlikely to reduce short term risk given the
>>>>>long half life of these drugs.
>>>>>5. For cancer patients who will be placed on IV bisphosphonates I urge
>>>>>restoration of dental health prior to beginning these drugs (as is also
>>>>>advised prior to beginning chemotherapy or XRT)and patient education to
>>>>>understand the risks/benefits of such drugs in these cases.
>>>>>6. I encourage patients to discuss these issues with the health care
>>>>>provider who is suggesting or prescribing bisphosphonates and always
>>>>>offer to discuss the OMFS literature and experience with those providers
>>>>>so that together with their health care providers they can make the best
>>>>>decision for their individual case.
>>>>>
>>>>>--
>>>>>Kim E. Goldman, D.M.D.
>>>>>Associates in Oral & Maxillofacial Surgery, PLC
>>>>>Asst. Clin. Prof. University of Louisville

--
art fougner, md
"I drank what?" - Socrates




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Jul 2 04:44:06 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.